VBL Therapeutics Announces Publication of Positive New Data on its Lecinoxoid Drug Candidates for the Treatment of Renal Fibrosis
Vascular Biogenics Ltd. - Ordinary Shares (VBLT)
Last vascular biogenics ltd. - ordinary shares earnings: 11/14 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
vblrx.com
Company Research
Source: GlobeNewswire
These data, together with positive preclinical NASH data previously presented, support the potential of VBL’s lecinoxoid pipelineRecently granted US patent provides patent protection for lecinoxoids treatment of fibrosis until at least November 2035 and supports potential partnering opportunities TEL AVIV, Israel, Aug. 30, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT) today announced the publication of a paper in the journal Basic and Clinical Pharmacology and Toxicology. The paper, titled “Lecinoxoids for Renal Inflammation and Fibrosis,” describes the role of the Company’s lead lecinoxoid drug candidates, VB-201 and VB-703, in inhibiting toll-like receptor activation and monocyte migration in a model of focal segmental glomerulosclerosis (FSGS), thereby slowing kidney function decline. The recently granted U.S. Patent No. 10,022,388, entitled "Oxidized Lipids and Treatment or Prevention of Fibrosis", provides VBL with intellectual property protection for the use of Ph
Show less
Read more
Impact Snapshot
Event Time:
VBLT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VBLT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VBLT alerts
High impacting Vascular Biogenics Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics